| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.14 | 0.009 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |